Devlin, Lori A. http://orcid.org/0000-0003-3826-4733
Young, Leslie W.
Kraft, Walter K. http://orcid.org/0000-0002-5074-0141
Wachman, Elisha M. http://orcid.org/0000-0002-6307-6999
Czynski, Adam
Merhar, Stephanie L.
Winhusen, T.
Jones, Hendrée E.
Poindexter, Brenda B.
Wakschlag, Lauren S.
Salisbury, Amy L.
Matthews, Abigail G.
Davis, Jonathan M.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U2C OD023375, U2C OD023375, R34 DA050268, RL1 HD104254, R01DA015778-5, NA)
U.S. Department of Health & Human Services | National Institutes of Health
Chiesi Farmaceutici (NA)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (UG1DA013732)
U.S. Department of Health & Human Services | National Institutes of Health
March of Dimes Foundation (NA)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 19 April 2021
Revised: 17 August 2021
Accepted: 3 September 2021
First Online: 23 September 2021
Competing interests
: The authors declare no competing interests.
Free to read: This content has been made available to all.